NCT07407933
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07407933
Title A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MediLink Therapeutics (Suzhou) Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Site 1001 NOT_YET_RECRUITING Washington D.C. District of Columbia 20057 United States Details
Site 1005 RECRUITING Houston Texas 77030 United States Details
Site 1002 RECRUITING Fairfax Virginia 22031 United States Details
Site 2201 RECRUITING London W12 0HS United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field